{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:28:27Z","timestamp":1779164907429,"version":"3.51.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10238-018-0500-y","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T08:12:11Z","timestamp":1523434331000},"page":"363-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"18","author":[{"given":"Neide Tomimura","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna Miglioranza","family":"Scavuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Mayumi Veiga","family":"Iriyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcell Alysson Batisti","family":"Lozovoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Frizon","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiano Aparecido","family":"de Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo C\u00e2ndido","family":"de S\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e2mela Lonardoni","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Alexandre","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna Maria Vissoci","family":"Reiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-6782","authenticated-orcid":false,"given":"Andr\u00e9a Name Colado","family":"Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaias","family":"Dichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"500_CR1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-857X(21)00886-3","volume":"16","author":"T Spector","year":"1990","unstructured":"Spector T. Rheumatoid arthritis. Rheum Dis Clin N Am. 1990;16:513\u201337.","journal-title":"Rheum Dis Clin N Am"},{"key":"500_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1201\/b16653-24","volume-title":"Role oxidative stress chronic diseases","author":"LP Blanco","year":"2014","unstructured":"Blanco LP, Ling S, Holoshitz J. Oxidative stress in rheumatoid arthritis: new insights. In: Dichi I, Bregan\u00f3 JW, Sim\u00e3o ANC, Cecchini R, editors. Role oxidative stress chronic diseases. 1st ed. Boca Raton: CRC Press; 2014. p. 481\u2013500.","edition":"1"},{"key":"500_CR3","doi-asserted-by":"publisher","first-page":"e0152925","DOI":"10.1371\/journal.pone.0152925","volume":"11","author":"S Mateen","year":"2016","unstructured":"Mateen S, Moin S, Khan AQ, Zafar A, Fatima N. Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis. PLoS ONE. 2016;11:e0152925.","journal-title":"PLoS ONE"},{"key":"500_CR4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/art.1780290411","volume":"29","author":"J Schalkwijk","year":"1986","unstructured":"Schalkwijk J, van der Berg W, van de Putte L, Joosten L. An experimental model for hydrogen peroxide-induced tissue damage. Effects of a single inflammatory mediator on (peri)articular tissues. Arthritis Rheum. 1986;29:532\u20138.","journal-title":"Arthritis Rheum"},{"key":"500_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/ar1447","volume":"6","author":"CA Hitchon","year":"2004","unstructured":"Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther. 2004;6:265\u201378.","journal-title":"Arthritis Res Ther"},{"key":"500_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/ard.54.6.505","volume":"54","author":"B Halliwell","year":"1995","unstructured":"Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis. 1995;54:505\u201310.","journal-title":"Ann Rheum Dis"},{"key":"500_CR7","doi-asserted-by":"publisher","first-page":"R234","DOI":"10.1186\/ar787","volume":"5","author":"S Hajizadeh","year":"2003","unstructured":"Hajizadeh S, DeGroot J, TeKoppele JM, Tarkowski A, Collins LV. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther. 2003;5:R234\u201340.","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 2","key":"500_CR8","first-page":"ii11","volume":"42","author":"SR Goldring","year":"2003","unstructured":"Goldring SR. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford). 2003;42(Suppl 2):ii11\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"500_CR9","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3109\/14397595.2014.891495","volume":"24","author":"A Nakajima","year":"2014","unstructured":"Nakajima A, Aoki Y, Shibata Y, Sonobe M, Terajima F, Takahashi H, et al. Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis. Mod Rheumatol. 2014;24:926\u201330.","journal-title":"Mod Rheumatol"},{"key":"500_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00296-007-0419-1","volume":"28","author":"Y Kageyama","year":"2008","unstructured":"Kageyama Y, Takahashi M, Nagafusa T, Torikai E, Nagano A. Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis. Rheumatol Int. 2008;28:245\u201351.","journal-title":"Rheumatol Int"},{"key":"500_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0300060515593227","volume":"44","author":"F Cacciapaglia","year":"2016","unstructured":"Cacciapaglia F, Grazia Anelli M, Rizzo D, Morelli E, Mazzotta D, Scioscia C, et al. Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis. J Int Med Res. 2016;44:28\u201332.","journal-title":"J Int Med Res"},{"key":"500_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12972","author":"K Kizaki","year":"2016","unstructured":"Kizaki K, Yamashita F, Hayashi T, Funakoshi N. Infliximab is equivalently suppressing oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis. Int J Rheum Dis. 2016. https:\/\/doi.org\/10.1111\/1756-185X.12972 .","journal-title":"Int J Rheum Dis"},{"key":"500_CR13","doi-asserted-by":"publisher","first-page":"e1887","DOI":"10.1038\/cddis.2015.246","volume":"6","author":"MS Chimenti","year":"2015","unstructured":"Chimenti MS, Triggianese P, Conigliaro P, Candi E, Melino G, Perricone R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis. 2015;6:e1887.","journal-title":"Cell Death Dis"},{"key":"500_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3109\/03009742.2011.626443","volume":"41","author":"V Cunha da","year":"2012","unstructured":"da Cunha V, Brenol CV, Brenol JC, Fuchs SC, Arlindo EM, Melo IM, et al. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand J Rheumatol. 2012;41:186\u201391.","journal-title":"Scand J Rheumatol"},{"key":"500_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-4939-1441-8_5","volume":"1208","author":"D Pierini","year":"2015","unstructured":"Pierini D, Bryan NS. Nitric oxide availability as a marker of oxidative stress. Methods Mol Biol. 2015;1208:63\u201371.","journal-title":"Methods Mol Biol"},{"key":"500_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.intimp.2004.11.013","volume":"5","author":"SVB Reddy","year":"2005","unstructured":"Reddy SVB, Wanchu A, Khullar M, Govindrajan S, Bambery P. Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis. Int Immunopharmacol. 2005;5:1085\u201390.","journal-title":"Int Immunopharmacol"},{"key":"500_CR17","first-page":"230","volume":"23","author":"Y Ueki","year":"1996","unstructured":"Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol. 1996;23:230\u20136.","journal-title":"J Rheumatol"},{"key":"500_CR18","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1172\/JCI118292","volume":"96","author":"H Sakurai","year":"1995","unstructured":"Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest. 1995;96:2357\u201363.","journal-title":"J Clin Invest"},{"key":"500_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-017-1131-x","volume":"15","author":"S-J Moon","year":"2017","unstructured":"Moon S-J, Kim E-K, Jhun JY, Lee HJ, Lee WS, Park S-H, et al. The active metabolite of leflunomide, A77 1726, attenuates inflammatory arthritis in mice with spontaneous arthritis via induction of heme oxygenase-1. J Transl Med. 2017;15:31.","journal-title":"J Transl Med"},{"key":"500_CR20","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/rheumatology\/keq388","volume":"50","author":"D Daoussis","year":"2011","unstructured":"Daoussis D, Kitas GD. Uric acid and cardiovascular risk in rheumatoid arthritis. Rheumatology. 2011;50:1354\u20135.","journal-title":"Rheumatology"},{"key":"500_CR21","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1186\/ar2775","volume":"11","author":"D Daoussis","year":"2009","unstructured":"Daoussis D, Panoulas V, Toms T, John H, Antonopoulos I, Nightingale P, et al. Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther. 2009;11:R116.","journal-title":"Arthritis Res Ther"},{"key":"500_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01991","volume":"425","author":"Y Shi","year":"2003","unstructured":"Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003;425:516\u201321.","journal-title":"Nature"},{"key":"500_CR23","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1681\/ASN.2005050572","volume":"16","author":"D-H Kang","year":"2005","unstructured":"Kang D-H, Park S-K, Lee I-K, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553\u201362.","journal-title":"J Am Soc Nephrol"},{"key":"500_CR24","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287\u201393.","journal-title":"Hypertension"},{"key":"500_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5049\/EBP.2014.12.1.1","volume":"12","author":"DH Kang","year":"2014","unstructured":"Kang DH, Ha SK. Uric acid puzzle: dual role as anti-oxidantand pro-oxidant. Electrolyte Blood Press. 2014;12:1\u20136.","journal-title":"Electrolyte Blood Press."},{"key":"500_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11926-010-0094-1","volume":"12","author":"M Mazzali","year":"2010","unstructured":"Mazzali M, Kanbay M, Segal M, Shafiu M, Jalal D, Feig D, et al. Uric acid and hypertension: cause or effect? Curr Rheumatol Rep. 2010;12:108\u201317.","journal-title":"Curr Rheumatol Rep"},{"key":"500_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cca.2014.07.039","volume":"438","author":"JY Choe","year":"2015","unstructured":"Choe JY, Kim SK. Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide. Clin Chim Acta. 2015;438:29\u201334.","journal-title":"Clin Chim Acta"},{"key":"500_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4137\/CMAMD.S38092","volume":"9","author":"JJ Lee","year":"2016","unstructured":"Lee JJ, Bykerk VP, Dresser GK, Boire G, Haraoui B, Hitchon C, et al. Reduction in serum uric acid may be related to methotrexate efficacy in early rheumatoid arthritis: data from the Canadian Early Arthritis Cohort (CATCH). Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:37\u201343.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"500_CR29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1517\/14728222.2012.723694","volume":"16","author":"ANC Sim\u00e3o","year":"2012","unstructured":"Sim\u00e3o ANC, Lozovoy MAB, Dichi I. The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome. Expert Opin Ther Targets. 2012;16:1175\u201387.","journal-title":"Expert Opin Ther Targets"},{"key":"500_CR30","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.nut.2008.03.021","volume":"24","author":"A Sim\u00e3o","year":"2008","unstructured":"Sim\u00e3o A, Dichi J, Barbosa D, Cecchini R, Dichi I. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition. 2008;24:675\u201381.","journal-title":"Nutrition"},{"key":"500_CR31","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"500_CR32","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/01.ATV.0000111245.75752.C6","volume":"24","author":"S Grundy","year":"2004","unstructured":"Grundy S, Brewer HJ, Cleeman J, Smith SJ, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Arterioscler Thrombolysis Vasc Biol. 2004;24:e13\u20138.","journal-title":"Arterioscler Thrombolysis Vasc Biol"},{"key":"500_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0891-5849(91)90002-K","volume":"10","author":"B Gonzalez Flecha","year":"1991","unstructured":"Gonzalez Flecha B, Llesuy S, Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med. 1991;10:93\u2013100.","journal-title":"Free Radic Biol Med"},{"key":"500_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994;233:357\u201363.","journal-title":"Methods Enzymol"},{"key":"500_CR35","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ki.1996.186","volume":"49","author":"V Witko-Sarsat","year":"1996","unstructured":"Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304\u201313.","journal-title":"Kidney Int"},{"key":"500_CR36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/clinchem\/44.3.679","volume":"44","author":"JA Navarro-Gonz\u00e1lvez","year":"1998","unstructured":"Navarro-Gonz\u00e1lvez JA, Garc\u00eda-Benayas C, Arenas J. Semiautomated measurement of nitrate in biological fluids. Clin Chem. 1998;44:679\u201381.","journal-title":"Clin Chem"},{"key":"500_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0009-8981(96)06394-2","volume":"255","author":"M Repetto","year":"1996","unstructured":"Repetto M, Reides C, Gomez Carretero ML, Costa M, Griemberg G, Llesuy S. Oxidative stress in blood of HIV infected patients. Clin Chim Acta. 1996;255:107\u201317.","journal-title":"Clin Chim Acta"},{"key":"500_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/10715760500053651","volume":"39","author":"D Tsikas","year":"2005","unstructured":"Tsikas D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res. 2005;39:797\u2013815.","journal-title":"Free Radic Res."},{"key":"500_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/ar3045","volume":"12","author":"G Nagy","year":"2010","unstructured":"Nagy G, Koncz A, Telarico T, Fernandez D, Ersek B, Buz\u00e1s E, et al. Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther. 2010;12:210.","journal-title":"Arthritis Res Ther"},{"key":"500_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.imlet.2008.02.009","volume":"118","author":"G Nagy","year":"2008","unstructured":"Nagy G, Clark JM, Buzas E, Gorman C, Pasztoi M, Koncz A, et al. Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis. Immunol Lett. 2008;118:55\u20138.","journal-title":"Immunol Lett"},{"key":"500_CR41","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","volume":"51","author":"AJ Farrell","year":"1992","unstructured":"Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis. 1992;51:1219\u201322.","journal-title":"Ann Rheum Dis"},{"key":"500_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1756-185X.2009.01375.x","volume":"12","author":"P Vasanthi","year":"2009","unstructured":"Vasanthi P, Nalini G, Rajasekhar G. Status of oxidative stress in rheumatoid arthritis. Int J Rheum Dis. 2009;12:29\u201333.","journal-title":"Int J Rheum Dis"},{"key":"500_CR43","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/rheumatology\/39.9.1004","volume":"39","author":"RJ van\u2019t Hof","year":"2000","unstructured":"van\u2019t Hof RJ, Hocking L, Wright PK, Ralston SH. Nitric oxide is a mediator of apoptosis in the rheumatoid joint. Rheumatology (Oxford). 2000;39:1004\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"500_CR44","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/ar2591","volume":"11","author":"T Sokka","year":"2009","unstructured":"Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study. Arthritis Res Ther. 2009;11:R7.","journal-title":"Arthritis Res Ther."},{"key":"500_CR45","first-page":"65","volume":"13","author":"GM Reaven","year":"1997","unstructured":"Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition. 1997;13:65 (discussion 64, 66).","journal-title":"Nutrition"},{"key":"500_CR46","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2337\/db06-1656","volume":"56","author":"L Fontana","year":"2007","unstructured":"Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010\u20133.","journal-title":"Diabetes"},{"key":"500_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cca.2006.04.002","volume":"372","author":"H Lemarechal","year":"2006","unstructured":"Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Kahan A, Ekindjian O, Borderie D. Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy. Clin Chim Acta. 2006;372:147\u201353.","journal-title":"Clin Chim Acta"},{"key":"500_CR48","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1590\/S0100-40422007000500046","volume":"30","author":"SML Vasconcelos","year":"2007","unstructured":"Vasconcelos SML, Goulart MOF, de Moura JBF, Benfato MS, Kubota LT. Reactive oxygen and nitrogen species, antioxidants and reactive oxygen and nitrogen species, antioxidants and markers of oxidative damage in human blood: main analytical methods for their determination. Quim Nova. 2007;30:1323\u201338.","journal-title":"Quim Nova"},{"key":"500_CR49","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.nutres.2015.06.013","volume":"35","author":"D Venturini","year":"2015","unstructured":"Venturini D, Sim\u00e3o ANC, Dichi I. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation. Nutr Res. 2015;35:759\u201365.","journal-title":"Nutr Res"},{"key":"500_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/cbf.1257","volume":"24","author":"G Baskol","year":"2006","unstructured":"Baskol G, Demir H, Baskol M, Kilic E, Ates F, Karakukcu C, et al. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Funct. 2006;24:307\u201311.","journal-title":"Cell Biochem Funct"},{"key":"500_CR51","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.7754\/Clin.Lab.2013.130143","volume":"60","author":"M Leitemperguer","year":"2014","unstructured":"Leitemperguer M, Tatsch E, Kober H, Moresco R. Assessment of ischemia-modified albumin levels in patients with rheumatoid arthritis. Clin Lab. 2014;60:1065\u201370.","journal-title":"Clin Lab"},{"key":"500_CR52","first-page":"1","volume":"2016","author":"NT Costa","year":"2016","unstructured":"Costa NT, Veiga Iriyoda TM, Kallaur AP, Delongui F, Alfieri DF, Lozovoy MAB, et al. Influence of insulin resistance and TNF on the inflammatory process, oxidative stress, and disease activity in patients with rheumatoid arthritis. Oxid Med Cell Longev. 2016;2016:1\u20139.","journal-title":"Oxid Med Cell Longev"},{"key":"500_CR53","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1177\/0961203311411350","volume":"20","author":"MAB Lozovoy","year":"2011","unstructured":"Lozovoy MAB, Sim\u00e3o ANC, Panis C, Rotter MAC, Reiche EMV, Morimoto HK, et al. Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus. Lupus. 2011;20:1250\u20139.","journal-title":"Lupus"},{"key":"500_CR54","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1007\/s12035-016-9860-z","volume":"54","author":"SR Oliveira","year":"2017","unstructured":"Oliveira SR, Kallaur AP, Reiche EMV, Kaimen-Maciel DR, Panis C, Lozovoy MAB, et al. Albumin and protein oxidation are predictors that differentiate relapsing-remitting from progressive clinical forms of multiple sclerosis. Mol Neurobiol. 2017;54:2961\u20138.","journal-title":"Mol Neurobiol"},{"key":"500_CR55","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/10715762.2015.1112901","volume":"50","author":"W Luczaj","year":"2016","unstructured":"Luczaj W, Gindzienska-Sieskiewicz E, Jarocka-Karpowicz I, Andrisic L, Sierakowski S, Zarkovic N, et al. The onset of lipid peroxidation in rheumatoid arthritis: consequences and monitoring. Free Radic Res. 2016;50:304\u201313.","journal-title":"Free Radic Res"},{"key":"500_CR56","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10067-006-0300-8","volume":"26","author":"A Isik","year":"2007","unstructured":"Isik A, Koca SS, Ustundag B, Celik H, Yildirim A. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin Rheumatol. 2007;26:342\u20138.","journal-title":"Clin Rheumatol"},{"key":"500_CR57","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s10067-012-2046-9","volume":"31","author":"GA Jacobson","year":"2012","unstructured":"Jacobson GA, Ives SJ, Narkowicz C, Jones G. Plasma glutathione peroxidase (GSH-Px) concentration is elevated in rheumatoid arthritis: a case-control study. Clin Rheumatol. 2012;31:1543\u20137.","journal-title":"Clin Rheumatol"},{"key":"500_CR58","first-page":"335","volume":"31","author":"S Kajanachumpol","year":"2000","unstructured":"Kajanachumpol S, Vanichapuntu M, Verasertniyom O, Totemchokchyakarn K, Vatanasuk M. Levels of plasma lipid peroxide products and antioxidant status in rheumatoid arthritis. Southeast Asian J Trop Med Public Health. 2000;31:335\u20138.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"500_CR59","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0009-9120(96)00007-0","volume":"30","author":"JK Gambhir","year":"1997","unstructured":"Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem. 1997;30:351\u20135.","journal-title":"Clin Biochem"},{"key":"500_CR60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejr.2011.07.002","volume":"33","author":"AM El-barbary","year":"2011","unstructured":"El-barbary AM, Khalek MAA, Elsalawy AM, Hazaa SM. Assessment of lipid peroxidation and antioxidant status in rheumatoid arthritis and osteoarthritis patients. Egypt Rheumatol. 2011;33:179\u201385.","journal-title":"Egypt Rheumatol"},{"key":"500_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/ard.50.2.81","volume":"50","author":"RD Situnayake","year":"1991","unstructured":"Situnayake RD, Thurnham DI, Kootathep S, Chirico S, Lunec J, Davis M, et al. Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates. Ann Rheum Dis. 1991;50:81\u20136.","journal-title":"Ann Rheum Dis"},{"key":"500_CR62","doi-asserted-by":"publisher","first-page":"e32668","DOI":"10.1371\/journal.pone.0032668","volume":"7","author":"D St\u00f6ckl","year":"2012","unstructured":"St\u00f6ckl D, D\u00f6ring A, Thorand B, Heier M, Belcredi P, Meisinger C. Reproductive factors and serum uric acid levels in females from the general population: the KORA F4 Study. PLoS ONE. 2012;7:e32668.","journal-title":"PLoS ONE"},{"key":"500_CR63","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/01.rhu.0000081470.31167.8b","volume":"9","author":"F Perez-Ruiz","year":"2003","unstructured":"Perez-Ruiz F, Nolla J. Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis. J Clin Rheumatol. 2003;9:215\u20138.","journal-title":"J Clin Rheumatol"},{"key":"500_CR64","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2165\/11316650-000000000-00000","volume":"32","author":"N Alcorn","year":"2009","unstructured":"Alcorn N, Saunders S, Madhok R. Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10\u00a0years after licensing. Drug Saf. 2009;32:1123\u201334.","journal-title":"Drug Saf"},{"key":"500_CR65","unstructured":"Osiri M, Shea B, Welch V, Suarez-Almazor ME, Strand V, Tugwell P, et al. Leflunomide for the treatment of rheumatoid arthritis. Cochrane Database Syst. Rev. 2009 (Review)."},{"key":"500_CR66","unstructured":"Haroui B. Leflunomide. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology, Philadelphia; 2015. p. 451\u20138."},{"key":"500_CR67","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/ard.62.5.440","volume":"62","author":"O Elkayam","year":"2003","unstructured":"Elkayam O, Yaron I, Shirazi I, Judovitch R, Caspi D, Yaron M. Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures. Ann Rheum Dis. 2003;62:440\u20133.","journal-title":"Ann Rheum Dis"},{"key":"500_CR68","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jbspin.2013.10.008","volume":"81","author":"D Arida","year":"2014","unstructured":"Arida D, Silva L, Skare T. The hypouricemiant effect of leflunomide. Jt Bone Spine. 2014;81:273\u20134.","journal-title":"Jt Bone Spine"},{"key":"500_CR69","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1136\/annrheumdis-2011-201027","volume":"71","author":"A Luczak","year":"2012","unstructured":"Luczak A, Knevel R, Huizinga TWJ, van Nies JAB, van der Helm-van Mil A, De Vries-Bouwstra JK. No impact of serum uric acid on the outcome of recent-onset arthritis. Ann Rheum Dis. 2012;71:1424\u20135.","journal-title":"Ann Rheum Dis"},{"key":"500_CR70","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/rheumatology\/kem159","volume":"46","author":"VF Panoulas","year":"2007","unstructured":"Panoulas VF, Milionis HJ, Douglas KMJ, Nightingale P, Kita MD, Klocke R, et al. Association of serum uric acid with cardiovascular disease in rheumatoid arthritis. Rheumatology. 2007;46:1466\u201370.","journal-title":"Rheumatology"},{"key":"500_CR71","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10067-010-1425-3","volume":"29","author":"H Kellner","year":"2010","unstructured":"Kellner H, Bornholdt K, Hein G. Leflunomide in the treatment of patients with early rheumatoid arthritis-results of a prospective non-interventional study. Clin Rheumatol. 2010;29:913\u201320.","journal-title":"Clin Rheumatol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-018-0500-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-0500-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-0500-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T15:41:11Z","timestamp":1751557271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-018-0500-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["500"],"URL":"https:\/\/doi.org\/10.1007\/s10238-018-0500-y","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]},"assertion":[{"value":"18 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the participants included in this study provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}